SCHEMBL5560937

SCHEMBL5560937

COCCOc1ccc2c(Oc3cc(-c4ccccc4)[nH]n3)ncnc2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM1A O60341 2/20 0.47
▸ RAF1 P04049 1/20 0.42
▸ BRAF P15056 1/20 0.42
▸ FGFR2 P21802 1/20 0.41
▸ CSF1R P07333 4/20 0.41
▸ PDGFRB P09619 1/20 0.41
▸ GRM4 Q14833 2/20 0.41
▸ EGFR P00533 5/20 0.39
▸ RAB9A P51151 2/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ KDR P35968 2/20 0.39
▸ ILK Q13418 2/20 0.39
▸ FGFR1 P11362 1/20 0.39
▸ FLT1 P17948 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ TRPA1 O75762 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL5566335 0.99 KDM1A (0.46) KDM1ARAF1BRAFFGFR2CSF1R
SCHEMBL5565868 0.84 KDM1A (0.56) KDM1ARAF1BRAFCSF1RPDGFRB
Hydrochloric Acid SCHEMBL5566986 0.83 KDM1A (0.55) KDM1ARAF1BRAFCSF1RPDGFRB
SCHEMBL5566656 0.82 KDM1A (0.53) KDM1ARAF1BRAFCSF1RPDGFRB
SCHEMBL7888723 0.81 KDM1A (0.52) KDM1ARAF1BRAFCSF1RPDGFRB
Hydrochloric Acid SCHEMBL5566338 0.81 KDM1A (0.52) KDM1ARAF1BRAFCSF1RPDGFRB
SCHEMBL5565927 0.79 KDM1A (0.54) KDM1ARAF1BRAFCSF1RPDGFRB
SCHEMBL5566781 0.78 EGFR (0.50) BRAFCSF1RPDGFRBEGFRKDR
SCHEMBL5565932 0.71 KDR (0.60) RAF1BRAFFGFR2CSF1RPDGFRB
SCHEMBL7884841 0.71 KDM1A (0.41) KDM1ABRAFCSF1RPDGFRBEGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7262201-B1 For the manufacture of a medicament for use in the production of an antiangiogenic and/or vascular permeability reducing effect in warm-blooded animals ASTRAZENECA AB (SE) 2007-08-28 — — US claimed
EP-1119567-B1 QUINAZOLINE DERIVATIVES ASTRAZENECA AB (SE) 2005-05-04 — — EP claimed
EP-1119567-A1 QUINAZOLINE DERIVATIVES AstraZeneca AB (SE) 2001-08-01 — — EP claimed
WO-2000021955-A1 QUINAZOLINE DERIVATIVES ASTRAZENECA AB (SE) 2000-04-20 — — WO claimed
US-7262201-B1 For the manufacture of a medicament for use in the production of an antiangiogenic and/or vascular permeability reducing effect in warm-blooded animals ASTRAZENECA AB (SE) 2007-08-28 — — US disclosed
EP-1119567-B1 QUINAZOLINE DERIVATIVES ASTRAZENECA AB (SE) 2005-05-04 — — EP disclosed
EP-1119567-A1 QUINAZOLINE DERIVATIVES AstraZeneca AB (SE) 2001-08-01 — — EP disclosed
WO-2000021955-A1 QUINAZOLINE DERIVATIVES ASTRAZENECA AB (SE) 2000-04-20 — — WO disclosed
Send feedback